Sign In
Buy ZLAB
$17.17
+0.0200 (+0.117%)
At Close: Jun 03, 2026
Zai Lab to Announce Second Quarter 2021 Financial Results
07:30am, Thursday, 22'nd Jul 2021
SHANGHAI and SAN FRANCISCO, July 22, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that it will report
Zai Lab: Best Now Capital Gain Biotech For Near-Term Wealth-Building, So Say Market-Makers
02:58pm, Sunday, 18'th Jul 2021
Like it or not, capital gain prospects for stocks in U.S. equities markets are all directly comparable with one another, and investors who want those gains need to make comparisons. The comparability
Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development
12:44pm, Wednesday, 30'th Jun 2021
Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development
Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology
07:30am, Wednesday, 16'th Jun 2021
SHANGHAI, SAN FRANCISCO and ROCKVILLE, MD, June 16, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, and MacroGenics (NASD
Week In Review: Zai Lab Enters $338 Million Agreement To In-License KRAS Inhibitor
11:57pm, Sunday, 06'th Jun 2021
Week In Review: Zai Lab Enters $338 Million Agreement To In-License KRAS Inhibitor
3 Stocks With Solid Balance Sheets for the Value Investor
10:08am, Thursday, 03'rd Jun 2021
Benjamin Graham, the father of value investing, suggested screening the market for stocks that have a current ratio of more than 2 plus more working capital than long-term debt.
Zai Lab Announces First Patient Treated in China in the Registrational Phase 2 TRIDENT-1 Study of Repotrectinib
07:30am, Friday, 28'th May 2021
SHANGHAI and SAN FRANCISCO, May 28, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company today announced dosing of the first pa
SHANGHAI and SAN FRANCISCO, May 24, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced treatment of the firs
Zai Lab Limited (ZLAB) CEO Samantha Du on Q1 2021 Results - Earnings Call Transcript
02:58pm, Monday, 10'th May 2021
Zai Lab Limited (ZLAB) CEO Samantha Du on Q1 2021 Results - Earnings Call Transcript
Zai Lab Announces First Quarter 2021 Financial Results
07:32am, Monday, 10'th May 2021
Company to Host Conference Call and Webcast Today at 8:00 a.m. EDT Company to Host Conference Call and Webcast Today at 8:00 a.m. EDT
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
04:11am, Monday, 26'th Apr 2021
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option
10:49am, Friday, 23'rd Apr 2021
SHANGHAI and SAN FRANCISCO, April 23, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB, HKEX: 9688), an innovative commercial stage biopharmaceutical company,
ZLAB Stock: Over 5% Increase Pre-Market Explanation
09:15am, Wednesday, 21'st Apr 2021
The stock price of Zai Lab Ltd (NASDAQ: ZLAB) increased by over 5% pre-market. This is why it happened.
Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares
07:40pm, Tuesday, 20'th Apr 2021
SHANGHAI and SAN FRANCISCO, April 20, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB, HKEX: 9688), an innovative commercial stage biopharmaceutical company,
ZLAB Stock: Over 5% Decrease Pre-Market Explanation
09:22am, Tuesday, 20'th Apr 2021
The stock price of Zai Lab Limited (NASDAQ:ZLAB) fell by over 5% pre-market. This is why it happened.
